BGM Group Ltd.
BGM Group Ltd is a Cayman Islands holding company with operating businesses primarily conducted through subsidiaries and variable interest entities in mainland China. Its operations span pharmaceutical and agricultural industrial products, including licorice products, oxytetracycline products, TCMD product, heparin product, sausage casings, and fertilizers, alongside a newer technology and biopharmaceutical focus.
Tilikausi 2025 · muutos edellisvuodesta
Kehitys 2020–2025
Liiketoiminta
Osuus liikevaihdostaIncludes oxytetracycline, heparin, and related biopharmaceutical products produced and sold in China.
Licorice-based products used in health, industrial, or food-related applications.
Includes fertilizers and other non-pharma industrial products sold to domestic customers.
Sausage casings and similar processing inputs used by food manufacturers and processors.
AI application, intelligent robot, and cloud-based services for insurance and related users.
Asiakkaat
The company serves industrial and commercial buyers that purchase pharmaceutical, agricultural, and food-processing inputs, with business primarily centered in China. It also targets insurance companies, insurance brokers, and consumers through AI-driven applications and intelligent services. Customer demand is tied to manufacturing usage, distribution relationships, and enterprise adoption of data-driven tools.
Buy oxytetracycline, heparin, and related products for medical or downstream formulation use.
Purchase licorice products and fertilizers for manufacturing, agricultural, or input use.
Buy sausage casings and related inputs for meat processing and packaged food production.
Use AI and intelligent-robot tools for sales, underwriting, claims, and customer service.
Interact with consumer-facing insurance and data-driven service applications.
Strategia
The company’s stated strategy combines its legacy biopharmaceutical and industrial product base with newer AI application, intelligent-robot, and cloud-computing capabilities. It is using AI-enabled platforms to serve insurance-related workflows while also integrating AI into biopharmaceutical production and supply-chain decisions. This mix suggests a diversification strategy that pairs operating businesses in China with a technology layer intended to improve customer service and operating efficiency.
Creates a higher-value service layer on top of insurance distribution and customer workflows.
Can improve production planning, supply-chain visibility, and market forecasting.
Reduces reliance on a narrow set of industrial products and expands addressable demand.
Maantiede
BGM Group Ltd is a U.S.-listed Cayman holding company whose business is mainly conducted in the People’s Republic of China through PRC subsidiaries and VIE structures. The company’s operating footprint is therefore concentrated in mainland China, even though the parent entity is offshore and the shares trade in the United States. This structure creates exposure to China-based supply chains, customers, regulation, and currency use in RMB.
Riskit
The business is exposed to China-specific regulatory, operating, and contractual-structure risk because most activities are conducted through PRC subsidiaries and VIEs. It also faces execution risk from managing two different business models: commodity-like product manufacturing and AI-enabled services. Customer credit, inventory valuation, goodwill, and long-lived asset impairment are all relevant because the company operates with trade receivables, manufacturing assets, and acquisition-related balances.
- China regulatory and operating riskVaikutus: KorkeaTodennäköisyys: Korkea
Most business activities are carried out in mainland China through PRC entities and VIEs.
Kohdistuu - VIE and contractual control structureVaikutus: KorkeaTodennäköisyys: Kohtalainen
Parts of the business are controlled through contractual arrangements rather than direct ownership.
Kohdistuu: RONS Intelligent and related PRC entities
- Goodwill impairmentVaikutus: KorkeaTodennäköisyys: Kohtalainen
Acquisition-related goodwill must be supported by future cash flow expectations.
Kohdistuu: Acquisition accounting
- Customer and trade receivable credit riskVaikutus: KeskitasoTodennäköisyys: Korkea
The company grants credit terms of up to 90 days and must estimate collectability.
Kohdistuu: Accounts receivable
- Inventory and long-lived asset valuationVaikutus: KeskitasoTodennäköisyys: Kohtalainen
Manufacturing and product businesses require estimates for inventory and asset impairment.
Kohdistuu
Kirjanpito
Harkinnanvaraiset erätCustomers may pay on credit terms up to 90 days, so collectability estimates affect receivables and earnings.
Manufacturing and product sales require estimates for obsolescence and realizable value.
Vaikutus: Can change cost of revenue and gross profit
Acquisition-related goodwill was recorded in the share-based transaction and must be tested for recoverability.
Vaikutus: Can create large non-cash charges
Plant, equipment, and other operating assets may need write-downs if cash flows weaken.
Vaikutus: Affects operating income and asset base
Cross-border structure and PRC operations can create judgmental tax positions and reserve needs.
Samankaltaisia listattuja yhtiöitä
Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.
Harrison Global Holdings Inc.
BLMZF · Services-Allied To Motion Picture Production
Lucas GC Ltd
LGCL · Services-Computer Programming, Data Processing, Etc.
Lucas GC Ltd is a U.S.-listed, Cayman Islands–incorporated AI technology company that operates a platform-as-a-service business using data analytics, blockchain, and software copyrights.
Zhongchao Inc.
ZCMD · Services-Educational Services
Tian'an Technology Group Ltd
TANAF · Motors & Generators
Tian'an Technology Group Ltd is a holding company whose operating activities are carried out through subsidiaries in Hong Kong and mainland China.
Big Tree Cloud Holdings Ltd
DSYWW · Converted Paper & Paperboard Prods (No Contaners/Boxes)
Big Tree Cloud Holdings Ltd is a U.S.-listed holding company with an operating focus described in filings as industrial integration and strategic investment in China’s personal care industry.
Jyong Biotech Ltd.
MENS · Pharmaceutical Preparations
Päivitetty: 28.9.2026